NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’
In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte
DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research
NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial
Cancer Prevention Fellowship Program Offers Enhancement
Trending Stories
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities